Shibata et al. [4] reported that adiponectin reversed cardiac hypertrophy in wild-type and transgenic obese mice by directly influencing the fat and glucose metabolism in cardiac myocytes via the adenosine monophosphate activated-protein kinase signaling pathway. Here, ADIPOQ is linked to cardiac hypertrophy.